RxDoctor Payments Data

Valerie McAuley, DO

Family Medicine · Exton, PANPI 1992841944

Payments from drug & device makers

$6,533in general payments, 2019–2025

Across 388 payments — averaging $16.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AstraZeneca$923
  • AbbVie$765
  • Pfizer$521
  • GSK$450
  • Boehringer Ingelheim$296
  • plus $2K from 51 others

What the payments were for

  • Food & beverage$6,44599%
  • Education$881%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,533 in reported general payments places this provider in the 90th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$199,586
Medicare patients
360
Services billed
3,509

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide65$70,217
Trelegy ElliptaFluticasone/Umeclidin/Vilanter74$55,132
ProliaDenosumab24$41,129
EliquisApixaban42$31,555
TrulicityDulaglutide16$24,700
LinzessLinaclotide32$16,717
FarxigaDapagliflozin Propanediol14$14,931
EntrestoSacubitril/Valsartan14$13,826
JanuviaSitagliptin Phosphate39$13,660
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$13,335
MovantikNaloxegol Oxalate11$7,314
QuviviqDaridorexant Hcl12$6,686
SymbicortBudesonide/Formoterol Fumarate18$4,552
DuleraMometasone/Formoterol12$4,336
Aripiprazole66$3,787

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,112$70,21765 claims
GSKTrelegy Ellipta$450$55,13274 claims
AmgenProlia$131$41,12924 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$923$32,81845 claims
PfizerEliquis$521$31,55542 claims
Lilly USA, LLCTrulicity$67$24,70016 claims
AbbVieLinzess, Synthroid$765$18,54758 claims
MerckJanuvia, Dulera$107$17,99551 claims
NovartisEntresto$91$13,82614 claims
Idorsia Pharmaceuticals US IncQuviviq$14$6,68612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in Exton

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →